ANTX

AN2 Therapeutics Inc

NASDAQ: ANTX · HEALTHCARE · BIOTECHNOLOGY

$4.89

+1.24% today

Updated 2026-09-24

Market cap

$182.27M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.05

Dividend yield

—

52W range

$1 – $7

Volume

0.2M

Market cap

$182.27M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.05

Dividend yield

—

52W range

$1 – $7

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.5

Quality

C+

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →260 stocks currently score above 75

Price targets

Analyst target

$9.00

+84.05%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-7.00M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-41.47M	$-64.73M	$-51.32M	$-35.17M	$-8.19M
EPS	—	—	—	—	$-1.05
Free cash flow	$-33.46M	$-53.29M	$-49.26M	$-29.83M	$-7.00M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ANTX	$182.27M	27	4.3	3.0	5.0	5.5	—	Avoid
LLY	$1.03T	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$648.67B	59	4.7	8.5	3.7	5.5	—	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-73.51%	Strong Buy
MRK	$365.34B	36	4.0	4.5	2.0	5.0	-78.20%	Hold
UNH	$333.27B	62	7.3	5.5	5.3	5.5	-14.85%	Buy

Smart narrative

AN2 Therapeutics Inc trades at $4.89. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score.

Frequently asked questions

What is AN2 Therapeutics Inc's stock price?

AN2 Therapeutics Inc (ANTX) trades at $4.89.

Is AN2 Therapeutics Inc overvalued?

AN2 Therapeutics Inc carries a Smart Value Score of 27/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of AN2 Therapeutics Inc (ANTX)?

The 12-month analyst consensus target is $9.00, about 84.0% above the current $4.89. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-42.26%

Beta-0.99

50D MA$5.46

200D MA$3.63

Shares out0.04B

Float0.02B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ANTX vs LLY →ANTX vs JNJ →ANTX vs ABBV →Stock screener →